AXT Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? AXT Inc trades at $79.32 (market cap $4.83B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: AXT Inc is far larger — about 9.6× Ginkgo Bioworks Holdings Inc's market cap, and AXT Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| AXTI | DNA | |
|---|---|---|
Market Cap | $4.83B | $505.73M |
Sector | Technology | Health |
52-Week High | $140.83 | $16.14 |
52-Week Low | $2.05 | $5.48 |
Enterprise Value | $4.50B | $607.68M |
Trailing returns across standard periods
Latest headlines on both assets
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →